Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023;11(1):37-43.
doi: 10.1007/s40136-023-00440-x. Epub 2023 Jan 27.

Recent Updates of Immunotherapy for Allergic Rhinitis in Children

Affiliations
Review

Recent Updates of Immunotherapy for Allergic Rhinitis in Children

Chih-Feng Lin et al. Curr Otorhinolaryngol Rep. 2023.

Abstract

Purpose of review: Allergen immunotherapy (AIT) is a novel treatment approach with disease-modifying and preventative benefits that are not shared with other strategies for treating allergic illnesses. It has been demonstrated to be safe and effective in children. This review provides the most recent information on AIT in children as well as any pertinent updates.

Recent findings: Although there is not a standard way to begin AIT, there are clear indications for AIT. Each case needs to be evaluated on its own by weighing the pros and downsides. AIT has been proven to significantly improve symptoms and quality of life in children with allergic illness, reduce medication use, stop the development of new allergen sensitizations, and stop the progression of allergic rhinitis to asthma. Novel approaches are under investigation to overcome some known AIT disadvantages.

Summary: This review provides a thorough summary of the most recent research and updates on AIT in children.

Keywords: Allergen immunotherapy; Allergic rhinitis; Atopy; Children; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestThe authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Pediatric allergic rhinitis diagnosis and management algorithm. HPF, high power field; IgE, immunoglobulin E
Fig. 2
Fig. 2
Mechanism of allergen immunotherapy

References

    1. Arrais M, Lulua O, Quifica F, Rosado-Pinto J, Gama JMR, Brito M, et al. Sensitisation to aeroallergens in relation to asthma and other allergic diseases in Angolan children: a cross-sectional study. Allergol Immunopathol (Madr) 2020;48(3):281–289. doi: 10.1016/j.aller.2019.10.005. - DOI - PubMed
    1. Christiansen ES, Kjaer HF, Eller E, Bindslev-Jensen C, Host A, Mortz CG, et al. The prevalence of atopic diseases and the patterns of sensitization in adolescence. Pediatr Allergy Immunol. 2016;27(8):847–853. doi: 10.1111/pai.12650. - DOI - PubMed
    1. Okubo K, Kurono Y, Ichimura K, Enomoto T, Okamoto Y, Kawauchi H, et al. Japanese guidelines for allergic rhinitis 2020. Allergol Int. 2020;69(3):331–345. doi: 10.1016/j.alit.2020.04.001. - DOI - PubMed
    1. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8(3):483–491. doi: 10.1183/09031936.95.08030483. - DOI - PubMed
    1. Bousquet J, Pfaar O, Togias A, Schunemann HJ, Ansotegui I, Papadopoulos NG, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy. 2019;74(11):2087–2102. doi: 10.1111/all.13805. - DOI - PubMed

LinkOut - more resources